Kura Oncology said it will present the first clinical results from its AML combination therapy studies with Kyowa Kirin at the 68th ASH Annual Meeting. The upda

Kura Oncology said it will present the first clinical results from its AML combination therapy studies with Kyowa Kirin at the 68th ASH Annual Meeting. The update adds to several abstracts and underscores continued clinical pipeline progress.